| Univariate analysis | Multivariate analysis |  | |
---|---|---|---|---|
 | PR (95% CI) | P value | PR (95% CI) | P value |
Sex | ||||
 Male | Reference | 0.295 |  |  |
 Female | 0.74 (0.42, 1.30) |  |  | |
Age, mean (SD) | 1.00 (0.99, 1.01) | 0.684 | Â | Â |
BMI | 1.02 (0.99, 1.05) | 0.191 | Â | Â |
Setting of Surgery | ||||
 - Tertiary Hospital | Reference | 0.878 | Reference | 0.947 |
 - Non- tertiaty hospital | 0.98 (0.71, 1.32) | 1.01 (0.75, 1.37) | ||
Tumor size (n = 306), mean (SD) | 1.01 (1.00, 1.02) | 0.001 | 1.01 (1.00, 1.02) | 0.182 |
Tumor focality, n (%) | ||||
 - Unifocal | Reference | 0.425 |  |  |
 - Multifocal | 1.13 (0.84, 1.53) |  |  | |
Positive Central Cervical Lymph nodes metastasis, n (%) | ||||
 - No | Reference | 0.004 | Reference | 0.017 |
 - Yes | 1.54 (1.15, 2.06) | 1.45 (1.07, 1.97) | ||
MACIS score | 1.14 (1.02, 1.28) | 0.017 | 1.08 (0.94, 1.24) | 0.285 |
Histology variant | ||||
 - Non- aggresive | Reference | 0.651 |  |  |
 - Aggresive | 1.11 (0.70, 1.79) |  |  | |
Risk recurrence | ||||
 Very low risk | Referencea |  |  |  |
 Low risk |  |  |  | |
 Indeterminate risk | 0.95 (0.51, 1.77) | 0.861 |  |  |
 High risk | 0.95 (0.19, 4.73) | 0.946 |  |  |